Task: Answer the multiple choice question.
Query: Which drug exhibits a 20.002\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CC(C)(C)C1CCC(C(=O)Nc2cccnc2)CC1
b) CCc1nnc(NC(=O)c2ccc(Br)c(S(=O)(=O)N3CCOCC3)c2)s1
Answer: b. CCc1nnc(NC(=O)c2ccc(Br)c(S(=O)(=O)N3CCOCC3)c2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1nnc(NC(=O)c2ccc(Br)c(S(=O)(=O)N3CCOCC3)c2)s1
CCc1nnc(NC(=O)c2ccc(Br)c(S(=O)(=O)N3CCOCC3)c2)s1
4-bromo-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-morpholin-4-ylsulfonylbenzamide